Global, regional, and national burden and quality of care index of liver cirrhosis by cause from global burden of disease 1990–2019

Cirrhosis and other chronic liver diseases are complex disorders with a known burden. Currently health systems have different approaches to dealing with this issue. The objective of this study is to describe the burden attributed to and quality of care for cirrhosis and other chronic liver diseases.

[1]  F. Farzadfar,et al.  Trends in Global, Regional, and National Burden and Quality of Care Index for Liver Cancer by Cause from Global Burden of Disease 1990‐2019 , 2022, Hepatology communications.

[2]  Yasuhito Tanaka,et al.  Seamless support from screening to anti-HCV treatment and HCC/ decompensated cirrhosis: Subsidy programs for HCV elimination. , 2021, Global health & medicine.

[3]  F. Farzadfar,et al.  Global, regional, and national survey on the burden and quality of care of pancreatic cancer: a systematic analysis for the Global Burden of Disease study 1990-2017. , 2021, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[4]  Z. Younossi,et al.  The global burden of cirrhosis: A review of disability-adjusted life-years lost and unmet needs. , 2021, Journal of hepatology.

[5]  F. Farzadfar,et al.  Global, regional, and national quality of care of ischaemic heart disease from 1990 to 2017: a systematic analysis for the Global Burden of Disease Study 2017. , 2021, European journal of preventive cardiology.

[6]  H. Gharib,et al.  Global, regional, and national burden and quality of care index (QCI) of thyroid cancer: A systematic analysis of the Global Burden of Disease Study 1990–2017 , 2021, Cancer medicine.

[7]  F. Farzadfar,et al.  A global, regional, and national survey on burden and Quality of Care Index (QCI) of brain and other central nervous system cancers; global burden of disease systematic analysis 1990-2017 , 2021, PloS one.

[8]  F. Farzadfar,et al.  A global, regional, and national survey on burden and Quality of Care Index (QCI) of hematologic malignancies; global burden of disease systematic analysis 1990–2017 , 2021, Experimental Hematology & Oncology.

[9]  U. Strömberg,et al.  Socioeconomic and marital status among liver cirrhosis patients and associations with mortality: a population-based cohort study in Sweden , 2020, BMC Public Health.

[10]  Eun Sug Park,et al.  Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2020, Lancet.

[11]  Dan J Stein,et al.  Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2020, Lancet.

[12]  S. Saab,et al.  Trends in the Burden of Chronic Liver Disease Among Hospitalized US Adults , 2020, JAMA network open.

[13]  T. H. Nguyen,et al.  The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2020, The lancet. Gastroenterology & hepatology.

[14]  M. Kurosaki,et al.  Transition in the etiology of liver cirrhosis in Japan: a nationwide survey , 2019, Journal of Gastroenterology.

[15]  M. Esmaeili,et al.  Quality of Life in Patients With Liver Cirrhosis: A Systematic Review , 2019, Hospital Practices and Research.

[16]  M. Coleman,et al.  The Mortality-to-Incidence Ratio Is Not a Valid Proxy for Cancer Survival , 2019, Journal of global oncology.

[17]  S. Terai,et al.  Considerations of elderly factors to manage the complication of liver cirrhosis in elderly patients , 2019, World journal of gastroenterology.

[18]  P. Kamath,et al.  Burden of liver diseases in the world. , 2019, Journal of hepatology.

[19]  Wei Jia,et al.  Gender differences in hepatocellular cancer: disparities in nonalcoholic fatty liver disease/steatohepatitis and liver transplantation , 2018, Hepatoma research.

[20]  S. Mohanty,et al.  Missed Diagnosis of Liver Cirrhosis Leads to Disparities in Care for Older Patients , 2018, Gastroenterology research.

[21]  W. Sung,et al.  Is mortality-to-incidence ratio associated with health disparity in pancreatic cancer? A cross-sectional database analysis of 57 countries , 2018, BMJ Open.

[22]  L. Boudarène,et al.  A systematic review of hepatitis B screening economic evaluations in low- and middle-income countries , 2018, BMC Public Health.

[23]  M. Saberifiroozi Improving Quality of Care in Patients with Liver Cirrhosis , 2017, Middle East journal of digestive diseases.

[24]  M. Kruk,et al.  Measuring quality of health-care services: what is known and where are the gaps? , 2017, Bulletin of the World Health Organization.

[25]  T. Kanto,et al.  Current activities and future directions of comprehensive hepatitis control measures in Japan: The supportive role of the Hepatitis Information Center in building a solid foundation , 2017, Hepatology research : the official journal of the Japan Society of Hepatology.

[26]  P. Pontisso,et al.  Hospitalizations Due to Cirrhosis: Clinical Aspects in a Large Cohort of Italian Patients and Cost Analysis Report , 2017, Digestive Diseases.

[27]  Chih-jen Wu,et al.  Influence of Age on Critically Ill Patients with Cirrhosis , 2015 .

[28]  Stephen A. Martin,et al.  Care that Matters: Quality Measurement and Health Care , 2015, PLoS medicine.

[29]  Y. Osaki,et al.  Liver Cirrhosis: Evaluation, Nutritional Status, and Prognosis , 2015, Mediators of inflammation.

[30]  A. Allen,et al.  Review article: the management of cirrhosis in women , 2014, Alimentary pharmacology & therapeutics.

[31]  Mohsen Naghavi,et al.  Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis , 2014, BMC Medicine.

[32]  A. Mosadeghrad,et al.  Healthcare Service Quality: Towards a Broad Definition , 2013, International journal of health care quality assurance.

[33]  M. Peters,et al.  Liver disease in women: the influence of gender on epidemiology, natural history, and patient outcomes. , 2013, Gastroenterology & hepatology.

[34]  N. Kemmer,et al.  Update on the management of cirrhosis – focus on cost-effective preventative strategies , 2013, ClinicoEconomics and outcomes research : CEOR.

[35]  M. Blachier,et al.  Report Title: The burden of liver disease in Europe: a review of available epidemiological data , 2013 .

[36]  Eliot J Lazar,et al.  Quality measurement in healthcare. , 2013, Annual review of medicine.

[37]  F. Cainelli Liver diseases in developing countries. , 2012, World journal of hepatology.

[38]  E. Schiff,et al.  The current economic burden of cirrhosis. , 2011, Gastroenterology & hepatology.

[39]  H. Sørensen,et al.  Socioeconomic status and survival of cirrhosis patients: A Danish nationwide cohort study , 2009, BMC gastroenterology.

[40]  Alvin C. Rencher,et al.  A Review Of “Methods of Multivariate Analysis, Second Edition” , 2005 .

[41]  G. Becker,et al.  Socioeconomic status and dissatisfaction with health care among chronically ill African Americans. , 2003, American journal of public health.

[42]  R H Brook,et al.  Can health care quality indicators be transferred between countries? , 2003, Quality & safety in health care.

[43]  E. Smith Methods of Multivariate Analysis , 1997 .

[44]  M. Kew,et al.  Progress towards the comprehensive control of hepatitis B in Africa: a view from South Africa. , 1996, Gut.

[45]  A. B. Sukhomlinov,et al.  [Liver cirrhosis]. , 1989, Fel'dsher i akusherka.